Selank on TikTok: separating Russian peptide research from hype
Quick answer
Selank is a synthetic tuftsin analog studied primarily in Russian clinical settings for generalized anxiety disorder and neurasthenic conditions, with proposed mechanisms involving GABA-A receptor modulation and enkephalin system effects. The creator reports complete elimination of anxiety and enhanced socialization after approximately one week of use, outcomes that exceed what current published trials demonstrate in terms of effect size and speed of onset. He also mentions adding additional unstacked peptides without clinical supervision, which introduces compounding safety variables that no existing literature has evaluated.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @collin.rice actually say?
In short: he says selank erased his anxiety completely, made him socialize with strangers like old friends, and gave him noticeable mental clarity, all within about a week of use. He also mentions stacking it with "axe" and a "deep delta sleep inducing peptide" and frames himself as a self-experimenting "lab rat."
His exact words: "I have literally no more anxiety anymore" and "I will never stop taking this shit." He draws a comparison to antidepressants and anti-anxiety medications to justify ongoing peptide use, which is a move worth examining. He also acknowledges, almost in passing, that it's "kind of sad" he needs something external to feel okay socially. That moment of self-awareness gets buried fast under enthusiasm, but it matters clinically.
Does the science back this up?
Partially, but the evidence base is thin and almost entirely preclinical or from small Russian trials. Selank is a synthetic heptapeptide analog of tuftsin, and it has shown anxiolytic effects in animal studies and a handful of human trials. But "handful" is doing heavy lifting here.
The most-cited human work comes from Filatova et al. (2007, Bulletin of Experimental Biology and Medicine), which found selank reduced anxiety scores in patients with generalized anxiety disorder and neurasthenia. Meshcheriakov et al. (1997) also documented reduced anxiety in small cohorts. The proposed mechanism involves modulation of GABA-A receptors and enkephalin metabolism, which is biologically plausible. Medvedev et al. (2014, Zhurnal Nevrologii i Psikhiatrii) noted effects on BDNF expression in rats. The socialization and "mental clarity" claims are much harder to pin to published data. No rigorous, large-scale, placebo-controlled RCT exists in Western peer-reviewed literature. Most studies are Russian, not replicated elsewhere, and involve small samples.
What did they get wrong (or right)?
He got the anxiety angle directionally right, the preclinical and limited clinical evidence does support anxiolytic properties for selank. Credit where it's due. The mechanism is not smoke and mirrors.
What he got wrong, or at least oversimplified: "I have literally no more anxiety anymore" after roughly one week is a red flag for placebo effect or expectation bias, not a disqualifying one, but a real one. Self-reported outcomes with no baseline measurement, no control, and strong prior expectation are notoriously unreliable. The socialization claims are largely unverifiable from published data. His framing of selank as equivalent to prescription anti-anxiety medications is misleading. Benzodiazepines and SSRIs have decades of randomized trial data behind them. Selank does not. Saying "people take anti-anxiety medications all the time" as a justification does not put selank in the same evidence category. It just doesn't.
The "lab rat" self-experimentation framing is a real risk. Stacking multiple peptides without clinical oversight, especially adding an unnamed "deep delta sleep inducing peptide," is not equivalent to a monitored protocol.
What should you actually know?
Selank is a research peptide. In the United States it is not FDA-approved for any condition. It is not a supplement. It is not a prescription medication you can get at a pharmacy. It occupies regulatory gray space, and quality control across suppliers varies significantly. That matters because purity, concentration, and sterility all affect both safety and any effect you might experience.
The anxiolytic evidence is real but limited. If you have clinical anxiety, a conversation with a licensed provider is the appropriate starting point, not a TikTok update. Selank may warrant more research attention, but "a weekend" of subjective improvement in a 49K-view video is not a clinical recommendation. The sleep peptide he mentions, likely delta sleep-inducing peptide (DSIP), has its own sparse and inconsistent evidence base. Stacking compounds with limited interaction data is a risk most people underestimate.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Selank on TikTok: separating Russian peptide research from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Selank on TikTok: separating Russian peptide research from hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Selank is a synthetic tuftsin analog studied primarily in Russian clinical settings for generalized anxiety disorder and neurasthenic conditions, with proposed mechanisms involving GABA-A receptor modulation and enkephalin system effects.
FormBlends verdict
Selank is a synthetic tuftsin analog studied primarily in Russian clinical settings for generalized anxiety disorder and neurasthenic conditions, with proposed mechanisms involving GABA-A receptor modulation and enkephalin system effects. The creator reports complete elimination of anxiety and enhanced socialization after approximately one week of use, outcomes that exceed what current published trials demonstrate in terms of effect size and speed of onset. He also mentions adding additional unstacked peptides without clinical supervision, which introduces compounding safety variables that no existing literature has evaluated.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Selank is a synthetic tuftsin analog studied primarily in Russian clinical settings for generalized anxiety disorder and neurasthenic conditions, with proposed mechanisms involving GABA-A receptor modulation and enkephalin system effects. The creator reports complete elimination of anxiety and enhanced socialization after approximately one week of use, outcomes that exceed what current published trials demonstrate in terms of effect size and speed of onset. He also mentions adding additional unstacked peptides without clinical supervision, which introduces compounding safety variables that no existing literature has evaluated.
- Selank is not FDA-approved for any condition and occupies regulatory gray space in the U.S., meaning supplier quality control is variable and unverified.
- Filatova et al. (2007) found anxiolytic effects in small GAD cohorts, but no large-scale placebo-controlled RCT in Western peer-reviewed literature has replicated these findings.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Selank is not FDA-approved for any condition and occupies regulatory gray space in the U.S., meaning supplier quality control is variable and unverified.
- Filatova et al. (2007) found anxiolytic effects in small GAD cohorts, but no large-scale placebo-controlled RCT in Western peer-reviewed literature has replicated these findings.
- One week of self-reported symptom resolution is not clinical evidence. Expectation bias in unblinded self-experimentation is well-documented across pharmacology research.
- Selank's proposed mechanism involving GABA-A modulation and enkephalin metabolism is biologically plausible, but plausibility is not the same as proven efficacy in humans.
- Stacking selank with DSIP or other peptides introduces interaction variables that have not been studied. No published data characterizes the combined safety or effect profile.
- Comparing selank to prescription anti-anxiety medication is not supported by the evidence. SSRIs and benzodiazepines have decades of randomized trial and post-market safety data behind them.
- If you are experiencing clinical anxiety, a licensed healthcare provider is the appropriate first contact, not a peptide sourced outside regulated pharmacy channels.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
collin.rice🍚🍙 · TikTok creator
49.2K views on this video
#selank #peptide #fyp #update
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by collin.rice🍚🍙, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.